NASDAQ$BTTC

Black Titan Corp · Q2 2012 earnings

Q2 2012 earnings · Reported Aug 9, 2012 (14 years ago) · Investor relations

Aug 9Jun 30, 2012

Total Revenue

$1.36M

Previous: $695K+95.7%

EPS (adj)

-$0.60

Previous: -$116.73+99.5%

Capital Expenditures

$467K

No prior period

Free Cash Flow

-$3.12M

No prior period

Net Income

-$1.72M

Previous: -$6.99M+75.3%

Operating Income

-$1.74M

Previous: -$4.2M+58.6%

Gross Profit

$1.36M

Previous: $695K+95.7%

Cash & Equivalents

$4.1M

No prior period

Total Assets

$10.1M

No prior period

Stock-Based Comp

$316K

No prior period

Titan Pharmaceuticals · Revenue · Quarterly

$1.36M

Q2 2012+95.7%vs Q2 2011

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation